Evidence map›Paper›PMID 40601695›Full record

ArticlePloS one2025

Have you heard of Rift Valley fever? Findings from a multi-country study in East and Central Africa.

Raymond Odinoh, Jeanette Dawa, Silvia Situma, Luke Nyakarahuka, Luciana Lepore, Veerle Vanlerberghe, Carolyne Nasimiyu, Sheila Makiala, Christian Ifufa, Daniel Mukadi and 7 more

Abstract read
In one paragraph

Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

17 authors.

Raymond OdinohWashington State University Global Health Program, Nairobi, Kenya.ORCID https://orcid.org/0009-0007-4298-2638
Jeanette DawaWashington State University Global Health Program, Nairobi, Kenya.ORCID https://orcid.org/0000-0001-9405-148X
Silvia SitumaWashington State University Global Health Program, Nairobi, Kenya.ORCID https://orcid.org/0000-0002-9257-4647
Luke NyakarahukaUganda Virus Research Institute, Entebbe, Uganda.ORCID https://orcid.org/0000-0002-2944-9157
Luciana LeporeInstitute of Tropical Medicine, Antwerp, Belgium.ORCID https://orcid.org/0000-0002-7965-8168
Veerle VanlerbergheInstitute of Tropical Medicine, Antwerp, Belgium.ORCID https://orcid.org/0000-0002-6531-0793
Carolyne NasimiyuWashington State University Global Health Program, Nairobi, Kenya.
Sheila MakialaInstitut National de la Recherche Biomédicale, Kinshasa, Democratic Republic of Congo.
Christian IfufaInstitut National de la Recherche Biomédicale, Kinshasa, Democratic Republic of Congo.
Daniel MukadiInstitut National de la Recherche Biomédicale, Kinshasa, Democratic Republic of Congo.
Herve VialaInstitut National de la Recherche Biomédicale, Kinshasa, Democratic Republic of Congo.
Nicholas OworUganda Virus Research Institute, Entebbe, Uganda.
Barnabas BakamutumahoUganda Virus Research Institute, Entebbe, Uganda.
Deo NdumuMinistry of Agriculture, Animal Industry and Fisheries, Entebbe, Uganda.
Justin MasumuInstitut National de la Recherche Biomédicale, Kinshasa, Democratic Republic of Congo.
Robert F BreimanRollins School of Public Health, Emory University, Atlanta, Georgia, United States of America.
Kariuki NjengaWashington State University Global Health Program, Nairobi, Kenya.

Funding

Emerging Infectious Diseases Research Center - East and Central AfricaU01AI151799 · NIAID · WASHINGTON STATE UNIVERSITY · PI M KARIUKI NJENGA · 2020 to 2026
$10.4M
Zoonotic and Emerging Infectious Diseases Training ProgramD43TW011519 · FIC · WASHINGTON STATE UNIVERSITY · PI Walter Godfrey Jaoko, Thumbi Mwangi · 2020 to 2026
$1.2M
FIC NIH HHS D43 TW011519NIAID NIH HHS U01 AI151799
6 · The paper itself

Abstract

introductionRift Valley Fever (RVF) has caused several outbreaks across Africa, impacting human health and animal trade. Recent reports indicate sporadic detections of RVF virus among humans and animals in East Africa during inter-epidemic periods. We assessed RVF knowledge levels in East and Central Africa across countries with different epidemiological profiles. MATERIALS AND

methodsIndividuals aged ≥10 years with acute febrile illness were enrolled from six health facilities in Kenya, Uganda, and the Democratic Republic of Congo (DRC). Sociodemographic information was collected, and participants were asked questions regarding their knowledge of RVF transmission, symptoms, prevention, and control. Blood samples were tested for anti-RVF antibodies (IgG and IgM). Knowledge was categorized as absent, basic, or advanced. Descriptive and ordinal logistic regression analysis identified factors associated with RVF knowledge.

resultsAmong 4,806 participants (median age 31, IQR 22-44, 57.5% female), only 20.5% had knowledge of RVF (16.4% basic, 4.1% advanced). Knowledge levels varied by country: DRC (3.1%), Uganda (16.1%), and Kenya (42.6%). RVF seropositivity was 10.4% in Uganda, with much lower rates in Kenya (2.0%) and DRC (1.5%). Factors associated with RVF knowledge included age 21-40 years (aOR 2.03; 95%CI 1,55-2.67) and >40 years (aOR 2.51; 95%CI 1.88-3.37), male gender (aOR 1.44; 95%CI 1.20-1.73), profession as a healthcare worker (aOR 5.63; 95%CI 3.48-9.12), residence in Kenya (aOR 26.8; 95%CI 15.8-48.4) or Uganda (aOR 5.43;95%CI 3.19-9.79), completing primary education (aOR 3.89; 95%CI 2.18-7.52) with advanced (postgraduate) education shown to increase knowledge, (aOR 22.8; 95%CI 4.95-18.6). Other factors included presence of livestock within the homes (aOR 1.26; 95%CI 1.01-1.57) and use of methods to prevent mosquito bites (aOR 1.62; 95%CI 1.32-1.98). Animal farmers, butchers, and those with close animal contact showed no association, despite being at-risk populations.

conclusionOverall RVF knowledge was low across the study sites, with the highest levels observed in Kenya, moderate levels in Uganda despite greater exposure, and markedly low levels in the DRC. Targeted risk communication is urgently needed for high-risk populations in all regions particularly in Uganda, where elevated exposure contrasts with limited knowledge. Increased awareness is crucial for high-exposure groups in all regions, particularly in Uganda where exposure is higher, but knowledge remains relatively low.

Indexed as

Health Knowledge, Attitudes, PracticeRift Valley FeverAdolescentAdultAfrica, CentralAfrica, EasternAnimalsAntibodies, ViralDemocratic Republic of the CongoFemaleHumansKenyaMaleMiddle AgedRift Valley fever virusUgandaAntibodies, Viral

Identifiers

PMID40601695
PMCPMC12221053

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.